• 1
    Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2009; 302: 17988.
  • 2
    Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004; 291: 17307.
  • 3
    Sattar N, Wannamethee G, Sarwar N et al. Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation 2006; 114: 6239. Erratum in: Circulation. 2007, 115(10):e325.
  • 4
    Wannamethee SG, Whincup PH, Lennon L, Sattar N. Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. Arch Intern Med 2007; 167: 15107.
  • 5
    Pilz S, Mangge H, Wellnitz B et al. Adiponectin and mortality in patients undergoing coronary angiography. J Clin Endocrinol Metab 2006; 91: 427786.
  • 6
    Menon V, Li L, Wang X et al. Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol 2006; 17: 2599606.
  • 7
    Paper Commenting Upon
  • 8
    Wannamethee SG, Welsh P, Whincup PH et al. High adiponectin and increased risk of cardiovascular disease and mortality in asymptomatic older men: does NT-proBNP help to explain this association? Eur J Cardiovasc Prev Rehabil 2011; 18: 6571.
  • 9
    McEntegart MB, Awede B, Petrie MC et al. Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide. Eur Heart J 2007; 7: 82935.
  • 10
    Tarnow L, Hildebrandt P, Hansen BV, Borch-Johnsen K, Parving HH. Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathy. Diabetologia 2005; 48: 14955.
  • 11
    Wannamethee SG, Welsh P, Lowe GD et al. NT-pro BNP is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease. J Am Coll Cardiol 2011; 58: 5664.
  • 12
    Cook JR, Semple RK. Hypoadiponectinemia – cause or consequence of human “insulin resistance”? J Clin Endocrinol Metab 2010; 95: 154454.
  • 13
    Choquet H, Cavalcanti-Proença C, Lecoeur C et al. The T-381C SNP in BNP gene may be modestly associated with type 2 diabetes: an updated meta-analysis in 49 279 subjects. Hum Mol Genet 2009; 18: 2495501.